For leaders in the Bow Valley, a landscape-altering wildfire on the scale of the fires that devastated Jasper, Fort McMurray, and Slave Lake is an inevitability. That’s why efforts are ramping ...

For leaders in the Bow Valley, a landscape-altering wildfire on the scale of the fires that devastated Jasper, Fort McMurray, and Slave Lake is an inevitability. That’s why efforts are ramping up to ...

Increasing wildfire prevention in the Bow Valley has long been a priority ... the tragedy that has recently struck our friends in Jasper and the devastation currently being felt in California ...

Work on the Bow Valley community fireguard commenced in the fall of 2024. "With the tragedy that has recently struck our friends in Jasper and the devastation currently being felt in California, our ...

1:55 Urgency mounts for fire mitigation in Alberta’s Bow Valley amid dry conditions ... ignite when the wildfire risk is high.” 5:11 Jasper mayor reflects on devastating 2024 wildfire Last ...

A rare Iron Age horse brooch has been made the subject of a temporary export ban in the hope it will be acquired by a UK museum. In 2023 the ornate metal object, found near Sutton Scotney ...

Alberta's federal bete noire is seen as the man with the power to secure Jasper's future after devastating wildfire. 'It's not going well' You can save this article by registering for free here.

As blazes continue to burn in L.A., Albertans know all-too-well the damage and misery that such massive walls of fire bring, including most recently July’s Jasper wildfire, and the behemoth Fort ...

On Wednesday, Jasper Therapeutics, Inc. JSPR reported preliminary data from the ongoing BEACON Phase 1b/2a study of subcutaneous briquilimab in adult participants with chronic spontaneous ...

Investing.com -- Shares of Jasper Therapeutics, Inc. (Nasdaq: JSPR) plummeted over 40% following the release of data from its BEACON study of Briquilimab in Chronic Spontaneous Urticaria (CSU).

REDWOOD CITY, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel ...